Skip to main content
42°
Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
News
Local News
State News
Sports
Local Sports
Pro Sports
Lifestyle
Local Entertainment
Multimedia
Community Choice
Features
Special Sections
Local Events
Weather
Classifieds
Place Ad
Legal Notices
Place Call Legal
Search Call Legals
Place Times Legal
Search Times Legals
Public Notices
Obituaries
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Vertex Pharmaceuticals Inc
Recent news which mentions Vertex Pharmaceuticals Inc
Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks
April 01, 2025
Tags
Gilead Sciences Inc
Amgen Inc
Merck & Co Inc
From
CNBC.com News
Jim Cramer says 'the market may be far healthier than we think.' Here's why
March 27, 2025
Tags
Investing
Chevron Corp
Business
From
CNBC.com News
Once high-flying Bluebird Bio sells itself to private equity after tough times for the gene therapy maker
February 21, 2025
Tags
Business News
Biotech and Pharmaceuticals
bluebird bio Inc
From
CNBC.com News
High-cost sickle cell gene therapies push insurers and Medicaid programs to find new payment models
February 18, 2025
Tags
bluebird bio Inc
Health insurance
Vertex Pharmaceuticals Inc
From
CNBC.com News
FDA approves Vertex’s non-opioid painkiller, first new kind of pain medicine in decades
January 30, 2025
Tags
Breaking News: Business
Business News
Health care industry
From
CNBC.com News
Cramer's Lightning Round: 'I would be a seller of QuantumScape'
January 08, 2025
Tags
U/S/ Markets
Pfizer Inc
Vertex Pharmaceuticals Inc
From
CNBC.com News
Cramer's Lightning Round: Vertex Pharmaceuticals is a buy
October 30, 2024
Tags
Stock Picks
Micron Technology Inc
Business News
From
CNBC.com News
Healthy Returns: Pfizer pulls sickle cell disease drug from markets – here’s why it matters
October 01, 2024
Tags
Healthy Returns
bluebird bio Inc
Pfizer Inc
From
CNBC.com News
Cramer's Lightning Round: Builders FirstSource 'can go higher'
August 28, 2024
Tags
stocks
Business News
Stock Picks
From
CNBC.com News
Cramer's Lighting Round: Vertex Pharmaceuticals is 'terrific'
April 08, 2024
Tags
Sibanye Stillwater Ltd
S&P 500
Investing
From
CNBC.com News
New sickle cell gene therapies are a breakthrough, but solving how to pay their high prices is a struggle
February 23, 2024
Tags
Eli Lilly and Co
Health insurance
Science
From
CNBC.com News
Vertex non-opioid painkiller shows positive results in critical late-stage trial on acute pain
January 30, 2024
Tags
Science
US: News
CRISPR Therapeutics AG
From
CNBC.com News
Vertex shares pop after non-opioid painkiller posts positive mid-stage trial results
December 13, 2023
Tags
Health care industry
Vertex Pharmaceuticals Inc
Breaking news
From
CNBC.com News
U.S. approves first gene-editing treatment, Casgevy, for sickle cell disease
December 08, 2023
Tags
Business
Government Agencies
Health & Science
From
CNBC.com News
U.S. poised to approve first gene-editing treatment in breakthrough for sickle cell patients
December 07, 2023
Tags
Business News
Biotech and Pharmaceuticals
bluebird bio Inc
From
CNBC.com News
Here are 16 stocks Jim Cramer is watching, including Microsoft, Chevron, Southwest
October 30, 2023
Tags
Comcast Corp
Southwest Airlines Co
Valley National Bancorp
From
CNBC.com News
20 stocks I'm watching in the market, including Emerson, DoorDash, Royal Caribbean
October 09, 2023
Tags
Stanley Black & Decker Inc
CNBC Investing Club
Investment strategy
From
CNBC.com News
Cramer says Vertex has a drug that may address the 'largest market opportunity in the world'
October 09, 2023
Tags
Investment strategy
Markets
CNBC Investing Club: Newsletter
From
CNBC.com News
Cramer's Lightning Round: Vertex is 'excellent'
October 05, 2023
Tags
Mad Money
Markets
Investment strategy
From
CNBC.com News
Stocks making the biggest moves after hours: Arista Networks, MGM Resorts, Stryker and more
May 01, 2023
Tags
Arista Networks Inc
Economy
Finance
From
CNBC.com News
Stocks making the biggest moves midday: Walgreens, Coinbase, Duolingo, Ralph Lauren and more
November 11, 2022
Tags
Ralph Lauren Corp
Morgan Stanley
Coinbase Global Inc
From
CNBC.com News
Cramer's lightning round: Stay with Vertex Pharmaceuticals
October 27, 2022
Tags
Investment strategy
Markets
Cleveland/Cliffs Inc
From
CNBC.com News
Stocks making the biggest moves after hours: Amazon, Apple, Pinterest, Intel and more
October 27, 2022
Tags
Intel Corp
Capital One Financial Corp
Pinterest Inc
From
CNBC.com News
Jim Cramer says investors should eye these three tech names in the Nasdaq 100
July 05, 2022
Tags
Alphabet Class A
Constellation Energy Corp
Align Technology Inc
From
CNBC.com News
Cramer's lightning round: I'm sticking with Marvell Technology
June 22, 2022
Tags
stocks
Business News
Rocket Companies Inc
From
CNBC.com News
Stocks making the biggest moves midday: Global Payments, Moderna, Activision Blizzard and more
May 02, 2022
Tags
Vertex Pharmaceuticals Inc
Finance
U/S/ Markets
From
CNBC.com News
Some of the first quarter’s biggest losers could be the biggest steals, Jim Cramer says
April 04, 2022
Tags
Exelon Corp
Business
Stock markets
From
CNBC.com News
Stem cells may finally offer a cure for Type 1 diabetes
March 26, 2022
Tags
Diabetes
Science
CRISPR Therapeutics AG
From
CNBC.com News
Op-ed: Investors should look at technology, health care and industrials for long-term investing potential
March 23, 2022
Tickers
WAR
Tags
Mettler/Toledo International Inc
Danaher Corp
W W Grainger Inc
From
CNBC.com News
The 30-year-old female founder at the forefront of a billion-dollar bet on CRISPR gene editing
March 12, 2022
Tags
Vertex Pharmaceuticals Inc
Small Business Playbook
Small business
From
CNBC.com News
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.